Serum Albumin Ratios Can Improve Sepsis Mortality Prediction
Key facts
- Who runs it
- Benha University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 30 Sept 2024
- Ended
- 30 Dec 2024
- Type of study
- Observational
- Treatments tested
- serum albumin
- C-Reactive Protein
- Serum procalcitonin
- Blood Lactate
- Record updated
- 28 November 2025
Who can take part
- Age
- 12 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients newly admitted to ICU with sepsis or septic shock
- Patients were free of exclusion criteria
Who cannot take part
- Patients with immunosuppressive or autoimmune disorders
- Patients with acute kidney injury
- Patients with hemorrhagic shock
- Patients suspected to die in ICU
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Sepsis remains a leading cause of mortality in hospitalized patients, despite advancements in critical care. Existing clinical scores for predicting sepsis outcomes often lack generalizability and complexity, hindering accurate risk assessment and timely intervention. This study aimed to evaluate the prognostic performance of serum albumin ratios to C-reactive protein (CRP), procalcitonin (PCT), and lactate in predicting 28-day morbidities and mortality in sepsis patients admitted to surgical ICUs. By incorporating these albumin ratios into clinical decision-making, we hypothesized that clinicians could more accurately identify patients at high risk of adverse outcomes and tailor treatment strategies accordingly.
The group in the trial
- Group 1
Patients newly admitted to ICU with sepsis or septic shock with manifestations suggestive of sepsis according to the guidelines of the 3rd International consensus definitions for sepsis and septic shock.
Treatment: serum albumin, C-Reactive Protein, Serum procalcitonin, and Blood Lactate
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Serum Albumin Ratios Correct the Ability of Traditional Biomarkers to Predict Mortality of Sepsis Patients Admitted to Surgical ICU
- Record updated
- 28 November 2025